Serious infections (eg, bloodstream infection, bone infections, respiratory tract infections, endocarditis, and septicemia):
due to gram-negative organisms, including Pseudomonas, Escherichia coli, Proteus, Providencia, Klebsiella, Enterobacter, Serratia, and Acinetobacter
藥理
Aminoglycoside antibiotic:
Inhibits protein synthesis in susceptible bacteria by binding to 30S ribosomal subunits
藥動學
Distribution:
1. Vd: 0.25 L/kg; primarily into extracellular fluid (highly hydrophilic)
2. Penetrates blood-brain barrier when meninges inflamed. Elimination Half-life: renal function and age dependent
1. Infants, low birth weight (1-3 days): 7-9 hrs
2. Infants, full-term >7 days: 4-5 hrs
3. Children: 1.6-2.5 hrs
4. Adults: Normal renal function: 1.4-2.3 hrs; Anuria/end-stage renal disease: 28-86 hrs Excretion: Urine (94% to 98%). Dialyzable( HD and PD).
禁忌症
1. Hypersensitivity to amikacin or other amino-glycosides antibiotics.
2. Patient with impaired renal function.
懷孕分類
D
哺乳分類
Infant risk cannot be ruled out.
副作用
Ototoxicity, nephrotoxicity, neurotoxicity
劑量和給藥方法
Adults: 15-20 mg/kg/day IM or IV, in divided doses Q8H or Q12H, maximum dose 1.5 g/day
小兒調整劑量
Infants and Children: 5-7.5 mg/kg/dose every 8 hours
腎功能調整劑量
Dosage adjustment: Loading dose 7.5 mg/kg, then according to ClCr (ml/min) to calculate maintenance dosage:
1. ClCr ≧60 mL/min: Administer Q8H
2. ClCr 40-60 mL/min: Administer Q12H
3. ClCr 20-40 mL/min: Administer Q24H
4. ClCr <20 mL/min: Loading dose, then monitor levels
5. Intermittent hemodialysis (administer after hemodialysis): 5-7.5 mg/kg Q48-72H
6. CVVH/CVVHD/CVVHDF: Loading dose of 10 mg/kg followed by maintenance dose of 7.5 mg/kg Q24-48H.
肝功能調整劑量
安定性
The original solution may discoloration during oxidation, this color change does not affect potency.